VERTEX PHARMACEUTICALS INC / MA Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for April 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,125 | 64,429 | 0 | |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 261.80 | 116 | 30,369 | 1,875 | 2 K to 1.9 K (-5.83 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 260.53 | 180 | 46,895 | 1,991 | 2.2 K to 2 K (-8.29 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 259.61 | 120 | 31,153 | 2,171 | 2.3 K to 2.2 K (-5.24 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 258.53 | 120 | 31,024 | 2,291 | 2.4 K to 2.3 K (-4.98 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 257.20 | 149 | 38,323 | 2,411 | 2.6 K to 2.4 K (-5.82 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 255.79 | 240 | 61,390 | 2,560 | 2.8 K to 2.6 K (-8.57 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 254.81 | 200 | 50,962 | 2,800 | 3 K to 2.8 K (-6.67 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,125 | 64,429 | 3,000 | 1.9 K to 3 K (+60.00 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 1,125 | |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 3,125 | |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 273.44 | 100 | 27,344 | 1,875 | 2 K to 1.9 K (-5.06 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.51 | 200 | 54,502 | 1,975 | 2.2 K to 2 K (-9.20 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.56 | 1,113 | 302,246 | 2,175 | 3.3 K to 2.2 K (-33.85 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.37 | 394 | 106,526 | 3,288 | 3.7 K to 3.3 K (-10.70 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.40 | 193 | 51,801 | 3,682 | 3.9 K to 3.7 K (-4.98 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.30 | 120 | 32,436 | 1,875 | 2 K to 1.9 K (-6.02 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.28 | 400 | 107,712 | 1,995 | 2.4 K to 2 K (-16.70 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.31 | 590 | 158,303 | 2,395 | 3 K to 2.4 K (-19.77 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.23 | 890 | 237,835 | 2,985 | 3.9 K to 3 K (-22.97 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 5,125 | |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 7,125 | |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 276.45 | 47 | 12,993 | 1,875 | 1.9 K to 1.9 K (-2.45 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 275.90 | 600 | 165,540 | 1,922 | 2.5 K to 1.9 K (-23.79 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 274.23 | 400 | 109,692 | 2,522 | 2.9 K to 2.5 K (-13.69 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.55 | 100 | 27,255 | 2,922 | 3 K to 2.9 K (-3.31 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.03 | 300 | 81,309 | 3,022 | 3.3 K to 3 K (-9.03 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.23 | 200 | 53,846 | 3,322 | 3.5 K to 3.3 K (-5.68 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.47 | 353 | 94,417 | 3,522 | 3.9 K to 3.5 K (-9.11 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.54 | 369 | 99,829 | 1,875 | 2.2 K to 1.9 K (-16.44 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.47 | 300 | 80,841 | 2,244 | 2.5 K to 2.2 K (-11.79 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.48 | 224 | 60,140 | 2,544 | 2.8 K to 2.5 K (-8.09 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.34 | 507 | 135,541 | 2,768 | 3.3 K to 2.8 K (-15.48 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 266.18 | 300 | 79,854 | 3,275 | 3.6 K to 3.3 K (-8.39 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 265.16 | 300 | 79,548 | 3,575 | 3.9 K to 3.6 K (-7.74 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 9,125 | |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 11,125 | |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.63 | 100 | 27,263 | 1,875 | 2 K to 1.9 K (-5.06 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.38 | 300 | 81,414 | 1,975 | 2.3 K to 2 K (-13.19 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.50 | 100 | 26,850 | 2,275 | 2.4 K to 2.3 K (-4.21 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.15 | 403 | 107,661 | 2,375 | 2.8 K to 2.4 K (-14.51 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 265.88 | 300 | 79,764 | 2,778 | 3.1 K to 2.8 K (-9.75 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 264.80 | 500 | 132,400 | 3,078 | 3.6 K to 3.1 K (-13.97 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 263.20 | 297 | 78,170 | 3,578 | 3.9 K to 3.6 K (-7.66 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 274.65 | 500 | 137,325 | 1,875 | 2.4 K to 1.9 K (-21.05 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 273.61 | 890 | 243,513 | 2,375 | 3.3 K to 2.4 K (-27.26 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.52 | 510 | 138,475 | 3,265 | 3.8 K to 3.3 K (-13.51 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.97 | 100 | 26,997 | 3,775 | 3.9 K to 3.8 K (-2.58 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 17 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 179 | 0 | 12,277 | |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 90.29 | 859 | 77,559 | 860 | |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 252.26 | 166 | 41,875 | 14,932 | 15.1 K to 14.9 K (-1.10 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 250.29 | 193 | 48,306 | 15,098 | 15.3 K to 15.1 K (-1.26 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 248.96 | 150 | 37,344 | 15,291 | 15.4 K to 15.3 K (-0.97 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 247.18 | 150 | 37,077 | 15,441 | 15.6 K to 15.4 K (-0.96 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 245.62 | 150 | 36,843 | 15,591 | 15.7 K to 15.6 K (-0.95 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 244.09 | 50 | 12,205 | 15,741 | 15.8 K to 15.7 K (-0.32 %) |
Apr 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 90.29 | 859 | 77,559 | 15,791 | 14.9 K to 15.8 K (+5.75 %) |
Apr 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 155.57 | 4,891 | 760,893 | 4,892 | |
Apr 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 255.57 | 4,891 | 1,249,993 | 14,932 | 19.8 K to 14.9 K (-24.67 %) |
Apr 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 155.57 | 4,891 | 760,893 | 19,823 | 14.9 K to 19.8 K (+32.76 %) |
Apr 02 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Payment of Exercise | F | 234.01 | 40,090 | 9,381,461 | 52,491 | 92.6 K to 52.5 K (-43.30 %) |